PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25907750-0 2015 Role of the D3 dopamine receptor in nicotine sensitization. Nicotine 36-44 dopamine receptor D3 Rattus norvegicus 12-32 25907750-8 2015 These data reveal important age-dependent regulation of DRD1- and DRD3-related mRNAs during the course of nicotine exposure. Nicotine 106-114 dopamine receptor D3 Rattus norvegicus 66-70 25907750-9 2015 Furthermore, they highlight a requirement for DRD3 signaling in the development of adolescent nicotine sensitization, suggesting it may represent an appropriate target in the prevention of nicotine dependence initiated at this age. Nicotine 94-102 dopamine receptor D3 Rattus norvegicus 46-50 25907750-9 2015 Furthermore, they highlight a requirement for DRD3 signaling in the development of adolescent nicotine sensitization, suggesting it may represent an appropriate target in the prevention of nicotine dependence initiated at this age. Nicotine 189-197 dopamine receptor D3 Rattus norvegicus 46-50 25907750-5 2015 Nicotine-induced changes were seen for DRD3 and D3nf mRNAs in the nucleus accumbens shell early in repeated exposure in both age groups. Nicotine 0-8 dopamine receptor D3 Rattus norvegicus 39-43 25762751-9 2015 During nicotine exposure, intact females displayed a decrease in CRF-R1, CRF-R2, Drd3, and Esr2 gene expression and an increase in CRF-BP. Nicotine 7-15 dopamine receptor D3 Rattus norvegicus 81-85 12494400-0 2003 Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Nicotine 83-91 dopamine receptor D3 Rattus norvegicus 10-30 20142301-1 2011 Our previous studies have shown that the selective dopamine D(3) receptor antagonists SB-277011A or NGB 2904 significantly attenuate cocaine self-administration under a progressive-ratio reinforcement schedule and cocaine-, methamphetamine- or nicotine-enhanced brain stimulation reward. Nicotine 244-252 dopamine receptor D3 Rattus norvegicus 51-73 19995481-0 2010 The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking. Nicotine 131-139 dopamine receptor D3 Rattus norvegicus 14-34 19995481-5 2010 SB 277011-A (1-10 mg/kg) was able to block cue-induced reinstatement of nicotine-seeking, indicating that DRD3 selective antagonism may be an effective approach to prevent relapse for nicotine. Nicotine 72-80 dopamine receptor D3 Rattus norvegicus 106-110 19995481-5 2010 SB 277011-A (1-10 mg/kg) was able to block cue-induced reinstatement of nicotine-seeking, indicating that DRD3 selective antagonism may be an effective approach to prevent relapse for nicotine. Nicotine 184-192 dopamine receptor D3 Rattus norvegicus 106-110 16942635-0 2006 The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Nicotine 65-73 dopamine receptor D3 Rattus norvegicus 14-34 16942635-0 2006 The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Nicotine 100-108 dopamine receptor D3 Rattus norvegicus 14-34 12610655-0 2003 Disruption of nicotine conditioning by dopamine D(3) receptor ligands. Nicotine 14-22 dopamine receptor D3 Rattus norvegicus 39-61